McInerney EM - Search Results

1

Estrogen receptors: selective ligands, partners, and distinctive pharmacology.

Katzenellenbogen BS, Montano MM, Ediger TR, Sun J, Ekena K, Lazennec G, Martini PG, McInerney EM, Delage-Mourroux R, Weis K, Katzenellenbogen JA. Katzenellenbogen BS, et al. Among authors: mcinerney em. Recent Prog Horm Res. 2000;55:163-93; discussion 194-5. Recent Prog Horm Res. 2000. PMID: 11036937 Review.

2

Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor.

Kraus WL, McInerney EM, Katzenellenbogen BS. Kraus WL, et al. Among authors: mcinerney em. Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12314-8. doi: 10.1073/pnas.92.26.12314. Proc Natl Acad Sci U S A. 1995. PMID: 8618892 Free PMC article.

3

Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation.

McInerney EM, Katzenellenbogen BS. McInerney EM, et al. J Biol Chem. 1996 Sep 27;271(39):24172-8. doi: 10.1074/jbc.271.39.24172. J Biol Chem. 1996. PMID: 8798658 Free article.

4

A transcriptionally active estrogen receptor mutant is a novel type of dominant negative inhibitor of estrogen action.

McInerney EM, Ince BA, Shapiro DJ, Katzenellenbogen BS. McInerney EM, et al. Mol Endocrinol. 1996 Dec;10(12):1519-26. doi: 10.1210/mend.10.12.8961262. Mol Endocrinol. 1996. PMID: 8961262

5

William L. McGuire Memorial Lecture. Antiestrogens: mechanisms of action and resistance in breast cancer.

Katzenellenbogen BS, Montano MM, Ekena K, Herman ME, McInerney EM. Katzenellenbogen BS, et al. Among authors: mcinerney em. Breast Cancer Res Treat. 1997 May;44(1):23-38. doi: 10.1023/a:1005835428423. Breast Cancer Res Treat. 1997. PMID: 9164675 Review.

6

Transcription activation by the human estrogen receptor subtype beta (ER beta) studied with ER beta and ER alpha receptor chimeras.

McInerney EM, Weis KE, Sun J, Mosselman S, Katzenellenbogen BS. McInerney EM, et al. Endocrinology. 1998 Nov;139(11):4513-22. doi: 10.1210/endo.139.11.6298. Endocrinology. 1998. PMID: 9794460

7

Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator.

McInerney EM, Tsai MJ, O'Malley BW, Katzenellenbogen BS. McInerney EM, et al. Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10069-73. doi: 10.1073/pnas.93.19.10069. Proc Natl Acad Sci U S A. 1996. PMID: 8816752 Free PMC article.

8

The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions.

Webb P, Nguyen P, Valentine C, Lopez GN, Kwok GR, McInerney E, Katzenellenbogen BS, Enmark E, Gustafsson JA, Nilsson S, Kushner PJ. Webb P, et al. Mol Endocrinol. 1999 Oct;13(10):1672-85. doi: 10.1210/mend.13.10.0357. Mol Endocrinol. 1999. PMID: 10517669

9

Molecular determinants of nuclear receptor-corepressor interaction.

Perissi V, Staszewski LM, McInerney EM, Kurokawa R, Krones A, Rose DW, Lambert MH, Milburn MV, Glass CK, Rosenfeld MG. Perissi V, et al. Among authors: mcinerney em. Genes Dev. 1999 Dec 15;13(24):3198-208. doi: 10.1101/gad.13.24.3198. Genes Dev. 1999. PMID: 10617569 Free PMC article.

10

Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators.

Westin S, Kurokawa R, Nolte RT, Wisely GB, McInerney EM, Rose DW, Milburn MV, Rosenfeld MG, Glass CK. Westin S, et al. Among authors: mcinerney em. Nature. 1998 Sep 10;395(6698):199-202. doi: 10.1038/26040. Nature. 1998. PMID: 9744281

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page